If an abnormal area is seen, a small piece of tissue will be removed (biopsy) and sent to a lab to be looked at carefully. A biopsy is the best way to tell for certain if an abnormal area is a ...

Quick surgeries are now routine, yet many insurance plans still demand 24-hour hospitalisation to honour claims—leaving ...

In the framework of computer-aided diagnosis of eye diseases, retinal vessel segmentation based on line operators is proposed. A line detector, previously used in mammography, is applied to the green ...

Objective IBD therapies and treatments are evolving to deeper levels of remission. Molecular measures of disease may augment current endpoints including the potential for less invasive assessments.

He or she will also do a physical exam and may order a biopsy to look at a small sample of the affected skin under a microscope. He or she may also order urine, blood and other tests to see if any ...

MariaDB has recently released MariaDB Community Server 11.8 as generally available, its yearly long-term support (LTS) release for 2025. The new release introduces integrated vector search capabilitie ...

GeneCentric Therapeutics has earned an initial $8m in a Series C funding round, marking a step towards the launch and commercialisation of GenomicsNext, an integrated platform for comprehensive liquid ...

In 2025, ASCO published a guideline update on the use of sentinel lymph node biopsy (SLNB) in patients with early-stage breast cancer (stages I and II) treated with up-front breast-conserving surgery.

Robotic-assisted bronchoscopy (RAB) for biopsy of peripheral pulmonary lesions (PPL) is associated with safe localization, access, and sampling of peripheral nodules, researchers reported in Chest.

Cincinnati-based Cryptic Vector has appointed John Fant, a business development and operations executive, as chief growth officer. In a statement published June 9, Cryptic Vector CEO Sean Olding ...

Global Liquid Biopsy Market Industry Overview The global liquid biopsy market was valued at $4,072.6 million in 2023 and is expected to reach $20,224.7 million by 2033, growing at a CAGR of 16.83%.

In many cases, early-stage prostate cancer will not spread or cause any problems or side effects for a long time, if ever. That’s why your health care provider may suggest active surveillance. This is ...